← All Heartbeam, INC filings

Heartbeam, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
BEAT
Heartbeam, INC
10-K: HeartBeam Advances Cardiac Monitoring Amid Going Concern
HeartBeam, Inc. reports significant progress in its 3D ECG technology with recent FDA clearances and initiates a limited market launch, despite ongoing concerns about its ability to continue as a going concern.
NASDAQ
BEAT
Heartbeam, INC
10-K: HeartBeam Inc. Reports 2024 Annual Results, Highlights FDA Clearance and Ongoing Development
HeartBeam Inc. announces its 2024 financial results, highlighting FDA clearance for its HeartBeam System and continued progress in developing its ambulatory cardiac monitoring solutions.
NASDAQ
BEAT
Heartbeam, INC
10-K: HeartBeam Inc. Files 10-K, Provides Update on FDA Submissions and Future Growth Plans
HeartBeam Inc.'s 10-K filing details their progress in developing cardiac monitoring technology, including FDA submissions and future market strategies.